Fig. 5From: Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case reportUltrasound findings pre- and post-trastuzumab therapy. A At the time of diagnosis. B After a single dose of trastuzumab monotherapy. Tumor diameter appeared to have shrunk overallBack to article page